As research deepens, the diagnosis and treatment of tumors have entered the era of "precision medicine," which is a new medical model on personalized medicine, integrating gene detection, bioinformatics, and big data science. This model can achieve early detection of tumors, precise diagnosis, precise classification, precise, and precise treatment. Therefore, in order to promote the standardized and normalized development of tumor pathology precision diagnosis, improve the accuracy of disease diagnosis, and further enhance business level of precision medicine and molecular pathology industry, and to promote the comprehensive, coordinated, and sustainable development of precision medicine and molecular pathology professionals. The "Training on Precision Detection and Standardized Diagnosis of Tumor Pathology (24-23-22-001-0104027)" co-sponsored by the Chengdu High-tech Medical Association and the Fifth People's Hospital of Chengdu, and hosted by the Western Precision Medicine and Molecular Path Committee of the Chengdu High-tech Medical Association, was successfully held on November 2, 2024. Pathology experts from all over the province together to explore new concepts and new progress in precision detection and standardized diagnosis of tumor pathology.

 The opening ceremony of the meeting was presided over by Yang Fan, director of the Western Precision Medicine and Molecular Pathology Committee of the Cheng High-tech Medical Association. Han Yiping, vice president of the association, attended the meeting and delivered a speech. He warmly welcomed the experts attending the meeting and affirmed the significance and necessity of the training course. He also expected to promote the development of the field of oncological pathology diagnosis and treatment through the platform of the.

There are many types of tumors, and accurate diagnosis is the foundation of precise treatment. Standardized diagnosis is an effective guarantee for accurate diagnosis The meeting invited Professor Wang Qiushi from the PLA Army Medical Center, Professor OuYang Nengtai from Sun Yat-sen University, Professor Yang Z from the First Affiliated Hospital of Kunming Medical University, Professor Tu Yuan from the Second People's Hospital of Chengdu, Professor Huang Zongyao from Affiliated Tumor Hospital of Electronic Science and Technology University, Professor Xia Liang and Professor Jiang Yong from Sichuan University's Huaxi Hospital, and Yang Fan from the Fifth People's Hospital of Chengdu to give lectures. The experts lectured on the standardization of clinical gene amplification testing laboratories, interpretation NGS reports, one-stop in-hospital implementation plan for tumor projects using NGS, localized construction of pathogenic microorganisms, and advances in MRD applications lymphoma, covering a wide range of topics with strong practicality.

This training is rich in content, practical, down-to-earth, and highly combat-effective, which not only deepens beginners' understanding and mastery basic knowledge of molecular pathology but also broadens the horizons of molecular pathology workers, helping to improve the diagnostic level of molecular pathology in primary hospitals, cultivate specialized, and promote the standardized application of molecular pathology detection technology and diagnosis.